CITADEL ADVISORS LLC

Holdings History for Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Symbol: LYEL on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.01%	-0%	$9,994,297	324,701	-14,790	-4.4%	$30.78	Q4 2025
31 Dec 2025	put	0%	-0%	$492,480	16,000	-750	-4.5%	$30.78	Q4 2025
30 Sep 2025		0%	+0%	$5,513,334	339,491	+68,208	+25%	$16.24	Q3 2025
30 Sep 2025	put	0%	+0%	$272,020	16,750	+760	+4.8%	$16.24	Q3 2025
30 Jun 2025		0%	+0%	$2,398,142	271,283	+271,283	NEW	$8.84	Q2 2025
30 Jun 2025	put	0%	+0%	$141,352	15,990	+15,990	NEW	$8.84	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.